CN102727752A - Application of Wu Hu Dan capsules in preparing medicine used for treating gout - Google Patents
Application of Wu Hu Dan capsules in preparing medicine used for treating gout Download PDFInfo
- Publication number
- CN102727752A CN102727752A CN2012102036155A CN201210203615A CN102727752A CN 102727752 A CN102727752 A CN 102727752A CN 2012102036155 A CN2012102036155 A CN 2012102036155A CN 201210203615 A CN201210203615 A CN 201210203615A CN 102727752 A CN102727752 A CN 102727752A
- Authority
- CN
- China
- Prior art keywords
- capsules
- gout
- application
- treating gout
- dan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an application of Wu Hu Dan capsules in preparing a medicine used for treating gout. The main components of the capsules are giant knotweed rhizome, sargenrgloryvine, salvia miltiorrhiza, appendiculate cremastra pseudobulb or common pleione pseudobulb, knoxia root, Chinese nut-gall, and artificial musk. The capsules are orally taken, 2 capsules once, and three times a day. The capsules provide functions of heat clearing, dampness eliminating, blood circulation activating, and bind dissipating. The capsules can be used in treating chronic nonspecific prostatitis heat accumulation and blood stasis. The capsules can be used for treating gout.
Description
Technical field
The present invention relates to a kind of new purposes of Chinese patent medicine, relate in particular to the application of Five Tiger Pellet capsule in preparation treatment gout medicine.
Background technology
Along with the change of The development in society and economy, dietary structure and the prolongation of human longevity, the sickness rate of gout improves day by day, has become the person in middle and old age's of the world today commonly encountered diseases.The existence of gout also can cause the deterioration of coronary heart disease, diabetes, hypertension etc., and human beings'health has been constituted potential threat.Modern medicine does not still have the radical cure method to primary disease at present.
Gout is that long-term purine metabolism obstacle and urate excretion reduce, blood uric acid increases the one group of clinical syndrome that causes tissue injury, and hyperuricemia is the most important biochemical character of gout.At present; Conventional therapy for gout and hyperuricemia is main with Western medicine still; Usually select chemicalses such as colchicine, nonsteroidal antiinflammatory drug, probenecid, allopurinol for use, these medicines reach the purpose of alleviating or treating gout and hyperuricemia with different effect links, though curative effect is all right; But increasing clinical observation finds that they all have certain toxic and side effects, and is especially more serious to person in middle and old age and the unsound patient's of hepatic and renal function side effect.
Chinese medicine and ethnic drug have characteristics such as toxicity is little, treating both the principal and secondary aspects of a disease, can improve symptom in acute stage, can regulate function in chronic phase and catabasis again, play and make body negative and positive of qi and blood balance, reduce effects such as recurrence.Therefore seeking with the Chinese herbal medicine is that the medicine of the treatment gout of primary raw material has caused numerous scientific and technical personnel's close attention, and the Chinese medicine gout has also become a current important topic.The Five Tiger Pellet capsule is the exclusive product of Daqing Huake Company Limited. Pharmacy filiale, does not also have the bibliographical information of its treatment gout at present.
Summary of the invention
Goal of the invention: the object of the present invention is to provide the application of Five Tiger Pellet capsule in preparation treatment gout medicine.
Technical scheme: the application of Five Tiger Pellet capsule in preparation treatment gout medicine.
Five Tiger Pellet capsule Main Ingredients and Appearance is Rhizoma Polygoni Cuspidati, Caulis Sargentodoxae, Radix Salviae Miltiorrhizae, Pseudobulbus Cremastrae Seu Pleiones, Radix Knoxiae, Galla Chinensis, artificial Moschus, and is oral, one time 2; 3 times on the one, ability clearing away heat-damp and promoting diuresis, blood circulation promoting and dispersing pathogen accumulation; Be used for the chronic nonspecific prostatitis damp-heat accumulation syndrome of blood stasis of holding concurrently, the present invention finds it can treat gout.
Beneficial effect: Five Tiger Pellet capsule for treating gout, respond well.
The specific embodiment
The clinical data of Five Tiger Pellet capsule for treating gout
Case is selected: through 30 routine clinical observations.Selecting the tcm diagnosis gout is standard: the patient has hyperuricemia, often in midnight the joint have an intense pain, the joint is red, swollen, hot, bitterly at ordinary times, limitation of activity, articular cavity has hydrops, tophus occurs and precipitates.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 11 examples, women's 9 examples do not have other serious disease, and the age is 37 years old-62 years old, 48.7 years old mean age.
Efficacy determination: produce effects: body constitution strengthens, on one's body energetically; Hyperuricemia is controlled, and red, swollen, hot, the pain in joint are obviously alleviated; Hydrarthrosis reduces.Effectively: body constitution strengthens, on one's body energetically; Red, swollen, hot, the pain in joint alleviate to some extent.Invalid: the disease no change.
During clinical experiment, take the Five Tiger Pellet capsule, one time 2,3 times on the one, observed 6 months, be a course of treatment, take 6 months after, symptom is obviously improved, 30 philtrums, produce effects 4 people, effective 24 people, invalid 2 people, total effective rate 93.33%.
Claims (1)
1. the application of Five Tiger Pellet capsule in preparation treatment gout medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102036155A CN102727752A (en) | 2012-06-19 | 2012-06-19 | Application of Wu Hu Dan capsules in preparing medicine used for treating gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102036155A CN102727752A (en) | 2012-06-19 | 2012-06-19 | Application of Wu Hu Dan capsules in preparing medicine used for treating gout |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102727752A true CN102727752A (en) | 2012-10-17 |
Family
ID=46984516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102036155A Pending CN102727752A (en) | 2012-06-19 | 2012-06-19 | Application of Wu Hu Dan capsules in preparing medicine used for treating gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102727752A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003004608A2 (en) * | 2001-07-06 | 2003-01-16 | Incyte Genomics, Inc. | Drug metabolizing enzymes |
| CN1429615A (en) * | 2003-01-30 | 2003-07-16 | 庹元斌 | Chinese medicine for treating prostatitis |
| US20040087796A1 (en) * | 2001-03-28 | 2004-05-06 | Harper Richard Waltz | Substituted carbazoles as inhibitors of spla2 |
| CN1883626A (en) * | 2006-05-30 | 2006-12-27 | 陕西九州生物科技股份有限公司 | Capsule for treating gout and preparation process thereof |
| CN1899439A (en) * | 2006-06-30 | 2007-01-24 | 杨熠锴 | Chinese medicine composition for treating goat and its use |
| CN101450154A (en) * | 2007-11-28 | 2009-06-10 | 天津金世制药有限公司 | Percutaneous absorption preparation for treating gout and preparation method thereof |
-
2012
- 2012-06-19 CN CN2012102036155A patent/CN102727752A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040087796A1 (en) * | 2001-03-28 | 2004-05-06 | Harper Richard Waltz | Substituted carbazoles as inhibitors of spla2 |
| WO2003004608A2 (en) * | 2001-07-06 | 2003-01-16 | Incyte Genomics, Inc. | Drug metabolizing enzymes |
| CN1429615A (en) * | 2003-01-30 | 2003-07-16 | 庹元斌 | Chinese medicine for treating prostatitis |
| CN1883626A (en) * | 2006-05-30 | 2006-12-27 | 陕西九州生物科技股份有限公司 | Capsule for treating gout and preparation process thereof |
| CN1899439A (en) * | 2006-06-30 | 2007-01-24 | 杨熠锴 | Chinese medicine composition for treating goat and its use |
| CN101450154A (en) * | 2007-11-28 | 2009-06-10 | 天津金世制药有限公司 | Percutaneous absorption preparation for treating gout and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102327449B (en) | Traditional Chinese medicine for treating gout | |
| CN102526327B (en) | Compound Chinese herbal medicine for treating rheumatoid bone disease and preparation method for compound Chinese herbal medicine | |
| CN1476849A (en) | Medicine composition for promoting blood circulation and removing stasis | |
| CN103301288A (en) | Traditional Chinese medicine composition for treating gouty arthritis | |
| CN100586473C (en) | Medicine for treating algomenorrhea | |
| CN105168922A (en) | Traditional Chinese medicine decoction for treating ulcerative colitis | |
| CN101940739A (en) | Traditional Chinese medicine for treating gout | |
| CN101745047A (en) | Chinese medicinal composition for treating gout disease and preparation method thereof | |
| CN102349990A (en) | Traditional Chinese medicine for treating hepatitis B | |
| CN104189363A (en) | Traditional Chinese medicinal herb for preventing and radically treating nephropathy | |
| CN103239562B (en) | Traditional Kazak medicament composition for treating diabetes mellitus and preparation method of traditional Kazak medicament composition | |
| CN100579544C (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
| CN104027622A (en) | Externally-applied traditional Chinese medicine for treating beriberi | |
| CN102727752A (en) | Application of Wu Hu Dan capsules in preparing medicine used for treating gout | |
| CN102406872B (en) | Traditional Chinese preparation for treating rheumatoid arthritis | |
| CN102784212A (en) | Chinese medicine composition for treating arthralgia-synadrome | |
| CN103316133B (en) | Medicine for treating lame impediment | |
| CN102302708A (en) | Medicament for chronic kidney disease (kidney deficiency and blood stasis) | |
| CN102657737B (en) | Medicament for treating acute gouty arthritis | |
| CN102430057B (en) | Medicinal composition for treating rheumatic pain | |
| CN101433711B (en) | Chinese medicinal composition for treating deafness | |
| CN1965967A (en) | Liquid having favorable effect on the treatment of hypertensive cerebral hemorrhage | |
| CN102861245A (en) | Medicine for preventing and treating gout disease | |
| CN105617347A (en) | Traditional Chinese medicine composition for treating chronic nephritis | |
| CN104771488A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| DD01 | Delivery of document by public notice |
Addressee: Bian Yuping Document name: Notification of Approving Refund |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20121017 |